Pilot Scale Troubleshooting for Dissolution Drift


Published on 01/06/2026

Troubleshooting Dissolution Drift During Pilot Scale Development

Developing a robust pharmaceutical product requires meticulous attention at every stage, particularly when transitioning from lab scale to pilot scale. A recent case study outlines a common yet critical issue: dissolution drift during pilot batch development. Professionals in the pharmaceutical industry can learn from this scenario, understanding how to manage such discrepancies effectively from detection to corrective action.

This article will provide a comprehensive approach to identifying symptoms, causes, and immediate actions taken. It will further detail the investigation workflow, root cause analysis tools, CAPA strategy, and controls that can help prevent future occurrences. Armed with this knowledge, pharmaceutical professionals can enhance their understanding of scale-up challenges and ensure inspection readiness.

Symptoms/Signals on the Floor or in the Lab

During a recent pilot batch of a solid dosage form, manufacturing personnel observed significant discrepancies in the dissolution profiles between laboratory and pilot scale. The symptoms included:

  • Variability in dissolution rates exceeding established specification limits.
  • Inconsistent release of active pharmaceutical ingredient (API) across different batches.
  • Visual differences in the physical characteristics of
the dosage forms, such as size and appearance.
  • Reports of impact in critical quality attributes (CQA) from Quality Control (QC) testing.
  • These signals indicated a need for immediate attention, as deviations at this scale could lead to regulatory repercussions, increased costs, and potential patient safety issues. Early recognition of these symptoms is crucial for effective intervention.

    Likely Causes (by category: Materials, Method, Machine, Man, Measurement, Environment)

    To uncover the root of the dissolution drift, we must consider a range of potential causes categorized as follows:

    Category Likely Cause
    Materials Variation in API particle size or excipient properties.
    Method Differences in testing procedures between lab scale and pilot scale.
    Machine Malfunction or miscalibration of dissolution testers at pilot scale.
    Man Operator error in the weighing or preparation stages.
    Measurement Inconsistencies in sample collection and analysis methodology.
    Environment Environmental conditions (temperature or humidity) differing from lab to pilot scale.

    Each potential cause must be scrutinized to ensure comprehensive understanding and effective remediation.

    Immediate Containment Actions (first 60 minutes)

    Upon observing the dissolution drift, immediate containment actions are vital. Within the first hour, the following steps were executed:

    • Stop the production line: Halt all ongoing operations to prevent compounding issues.
    • Isolate affected batches: Segregate all materials and products associated with the implicated pilot batch.
    • Quarantine samples: Retain samples of the affected batches for further investigation and testing.
    • Notify stakeholders: Inform key personnel from manufacturing, quality control, and quality assurance.
    • Initiate documentation: Begin documentation of the incident as per internal SOPs for deviations.

    These actions prevent the issue from escalating while also safeguarding data integrity and regulatory compliance.

    Investigation Workflow (data to collect + how to interpret)

    The investigation workflow should systematically collect and analyze relevant data to discern the underlying cause of the dissolution drift. Steps include:

    • Gather operational data: Collect records on batch manufacturing conditions (temperature, humidity, mixing times).
    • Review dissolution method: Compare dissolution testing protocols employed on the lab scale against those used in the pilot.
    • Analyze material properties: Inspect raw material specifications and any recent changes or variations in suppliers.
    • Collect QC data: Review dissolution profiles from both lab and pilot testing along with out-of-specification (OOS) reports.
    • Conduct operator interviews: Speak with the personnel who executed the pilot batch to identify any deviations from standard procedures.

    By meticulously interpreting this data, a clearer picture of the contributing factors can be developed, allowing targeted investigation of the anomalies.

    Root Cause Tools (5-Why, Fishbone, Fault Tree) and when to use which

    Employing root cause analysis (RCA) tools is critical to detecting the fundamental reasons for the issue. Here’s when and how to use key tools:

    • 5-Why Analysis: Ideal for straightforward problems where addressing the hierarchy of causes can elucidate the issue with depth. Example: “Why did the dissolution fail? Because the API particle size was inaccurate. Why was the size inaccurate? Because of improper weighing…”
    • Fishbone Diagram: Suitable for complex issues involving multiple variables. This diagram lays out potential causes visually across various categories (Man, Machine, Method, etc.) and helps to foster discussion and classification.
    • Fault Tree Analysis: Effective for systems where faults must be evaluated meaningfully. It delves into the relationships between different failures and drives focus on systemic improvements.

    Choosing the appropriate tool depends on the issue’s complexity and the type of data available, helping ensure a thorough understanding of causal factors.

    CAPA Strategy (correction, corrective action, preventive action)

    Once the root cause has been identified, an effective CAPA strategy should be implemented:

    • Correction: Address the immediate issue. For instance, recalibrate the dissolution machine and revalidate the testing procedure, ensuring precision consistency.
    • Corrective Action: Implement changes to prevent recurrence, which may involve retraining personnel on pilot equipment protocols, ensuring operators adhere to specification rigorously.
    • Preventive Action: Broader measures to enhance overall operational robustness. This may include periodic review and validation of dissolution methods, along with greater responsibility for material source evaluation.

    Documenting each step thoroughly adheres to regulatory expectations and promotes transparency throughout the process.

    Control Strategy & Monitoring (SPC/trending, sampling, alarms, verification)

    An effective control strategy with monitoring mechanisms is essential to ensure ongoing compliance and quality assurance. This might include:

    • Statistical Process Control (SPC): Apply SPC techniques for monitoring dissolution rates to detect variations early.
    • Trending Analysis: Develop a trending analysis of dissolution tests across multiple batches to identify potentially systemic deviations before they become problematic.
    • Automated Alarming Systems: Integrate alarms within the dissolution testing apparatus to signal deviations beyond predefined thresholds, prompting immediate operator investigation.
    • Regular Verification: Schedule routine verification of processes and equipment. Ensure that both lab and pilot scales undergo regular calibration checks to maintain accuracy.

    This comprehensive structure provides the foundation to sustain quality manufacturing and facilitate responsiveness to any operational irregularities.

    Related Reads

    Validation / Re-qualification / Change Control impact (when needed)

    In instances of significant change due to root cause findings, validation, and re-qualification processes may be impacted. Potential actions include:

    • Validation of Equipment: Re-validate the effectiveness of dissolution sampling apparatus following any calibration or maintenance procedures.
    • Re-qualification of the Method: If a new dissolution method or adjustment is introduced, a re-qualification may be necessary to ensure performance aligns with regulatory expectations.
    • Change Control Documentation: Any changes made during the investigation and CAPA process should be thoroughly documented through a change control procedure to ensure traceability and compliance.

    Implementing these protocols ensures that the manufacturing processes remain compliant and consistently produce high-quality products.

    Inspection Readiness: what evidence to show (records, logs, batch docs, deviations)

    To ensure inspection readiness following the resolution of this issue, maintain a comprehensive documentation trail. Key documents to present during an inspection include:

    • Batch Records: Ensure all batch production records are up-to-date and clearly reflect the investigation findings and corrective actions taken.
    • Quality Control Logs: Document QC testing outcomes and confirm that discrepancies have been followed up according to standard procedures.
    • Deviation Reports: Keep detailed deviation reports from the incident, including the investigation’s findings and the CAPA measures employed.
    • Training Records: Maintain records of all personnel retrained on procedures and best practices in response to the identified issues.
    • Periodic Review Reports: Keep records of the ongoing review processes instituted to mitigate future risks.

    This robust documentation not only demonstrates compliance with regulatory bodies such as the FDA, EMA, and MHRA but also reinforces the proactive stance of the manufacturing organization.

    FAQs

    What is dissolution drift?

    Dissolution drift refers to the inconsistency observed in dissolution profiles when comparing batches produced at different scales, affecting product quality.

    How can I prevent dissolution drift when scaling up?

    Prevent dissolution drift by validating processes rigorously, ensuring that equipment is properly calibrated, and adhering closely to established sampling and testing methods.

    What are the best practices for CAPA documentation?

    Follow best practices by documenting every action taken, including corrections, root cause findings, preventive measures, and validation outcomes to ensure regulatory compliance and readiness.

    When should I initiate a deviation report?

    A deviation report should be initiated any time there are significant discrepancies in manufacturing outcomes that deviate from established protocols or specifications.

    What tools are effective for root cause analysis?

    Commonly used tools for root cause analysis include the 5-Why technique, Fishbone diagrams, and Fault Tree analysis, each suitable for various complexity levels of problems.

    Is SPC necessary for pilot scale processes?

    Yes, implementing Statistical Process Control (SPC) in pilot scale processes can help identify variations early and prevent quality issues from escalating.

    What role does training play in preventing scale-up issues?

    Regular training ensures that personnel are updated on changes in processes and best practices, reducing the likelihood of operator error contributing to scale-up issues.

    How often should equipment be calibrated?

    Equipment should be calibrated routinely as part of preventive maintenance programs, with frequency depending on its use and the specific regulatory requirements in place.

    What are the consequences of not managing dissolution drift?

    Failure to manage dissolution drift can lead to regulatory non-compliance, costly product recalls, and, ultimately, jeopardizing patient safety and organizational integrity.

    How should I document changes after a CAPA?

    Document changes through a structured change control process, ensuring clarity around the rationale, implementation details, and verification measures taken post-change.

    What is the importance of trend analysis in quality control?

    Trend analysis identifies patterns over time, helping organizations discern systemic issues before they impact production or product quality significantly.

    If you find our Articles useful
    Add us as preferred source on Google
    Pharma Tip:  Pilot Batch Planning Checklist for Early Pharmaceutical Scale-Up
    If you find our Articles useful
    Add us as preferred source on Google